United States · FDA National Drug Code directory
Oxaprozin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70512-787_450f5941-7f11-42fe-e063-6394a90a4803
- Product NDC
- 70512-787
- Form
- CAPSULE
- Composition / generic term
- Oxaprozin
- Labeler
- SOLA Pharmaceuticals, LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20251203
- Source listing expiry
- 20261231
Source-listed ingredients
- OXAPROZIN — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 CAPSULE in 1 BOTTLE (70512-787-60) · 70512-787-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →